RLCAX
Price
$8.89
Change
+$0.06 (+0.68%)
Updated
Jul 3 closing price
Net Assets
176.02M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

RLCAX vs VVIAX

Header iconRLCAX vs VVIAX Comparison
Open Charts RLCAX vs VVIAXBanner chart's image
Columbia Disciplined Value A
Price$8.89
Change+$0.06 (+0.68%)
VolumeN/A
Net Assets176.02M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
RLCAX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RLCAX vs. VVIAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLCAX is a StrongBuy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. RLCAX (176M). VVIAX pays higher dividends than RLCAX: VVIAX (2.18) vs RLCAX (1.40). RLCAX was incepted earlier than VVIAX: RLCAX (17 years) vs VVIAX (25 years). RLCAX (1.21) is less costly to investors than VVIAX (0.05). RLCAX is a more actively managed with annual turnover of: 60.00 vs. VVIAX (9.00). RLCAX has a lower initial minimum investment than VVIAX: RLCAX (2000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. RLCAX (3.72). VVIAX return over 5 years is better than : 80.13 vs. RLCAX (19.86).
RLCAXVVIAXRLCAX / VVIAX
Total Expense Ratio1.030.052,060%
Annual Report Gross Expense Ratio1.210.052,420%
Fund Existence17 years25 years-
Gain YTD5.7076.19892%
Front Load6%N/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets176M189B0%
Annual Yield % from dividends1.402.1864%
Returns for 1 year3.7212.0331%
Returns for 3 years12.2935.1735%
Returns for 5 years19.8680.1325%
Returns for 10 years3.07115.673%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MYRG188.885.60
+3.06%
MYR Group
BOLT5.920.01
+0.17%
Bolt Biotherapeutics Inc
PGY22.16-0.02
-0.09%
Pagaya Technologies Ltd
OMC74.71-0.31
-0.41%
Omnicom Group
ACTU6.59-0.15
-2.23%
Actuate Therapeutics Inc